indapamide has been researched along with Anterior Circulation Transient Ischemic Attack in 15 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was a subsidiary analysis of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)--a randomized, placebo-controlled trial that established the beneficial effects of blood pressure--lowering in a heterogeneous group of patients with cerebrovascular disease." | 9.11 | Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. ( Anderson, C; Arima, H; Chalmers, J; Colman, S; Hart, RG; MacMahon, S; Neal, B; Rodgers, A; Woodward, M, 2005) |
| "The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)." | 9.09 | PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999) |
| "1709 patients with history of stroke or transient ischaemic attack randomised to fixed doses of perindopril and indapamide." | 5.14 | Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. ( Hayen, A; Irwig, L; Keenan, K; Neal, BC, 2009) |
| "Analyses of the risks of stroke were conducted for subjects with and without diabetes, participating in a randomized, double-blind, placebo-controlled trial of a perindopril-based blood pressure lowering regimen in 6105 people with prior stroke or transient ischaemic attack (TIA), followed for a median of 3." | 5.11 | Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial. ( Berthet, K; Bousser, MG; Chalmers, JP; Colman, SA; MacMahon, SW; Neal, BC; Woodward, M, 2004) |
| "This study was a subsidiary analysis of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)--a randomized, placebo-controlled trial that established the beneficial effects of blood pressure--lowering in a heterogeneous group of patients with cerebrovascular disease." | 5.11 | Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. ( Anderson, C; Arima, H; Chalmers, J; Colman, S; Hart, RG; MacMahon, S; Neal, B; Rodgers, A; Woodward, M, 2005) |
| "Among individuals with cerebrovascular disease, a perindopril-based blood pressure-lowering regimen not only reduced the risk of stroke and major vascular events but also substantially reduced the risks of associated long-term disability and dependency." | 5.10 | Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. ( Anderson, C; Chalmers, J; Chapman, N; Davis, S; Fransen, M; MacMahon, S; Neal, B; Sega, R; Terent, A; Tzourio, C; Woodward, M, 2003) |
| "The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)." | 5.09 | PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999) |
| "The Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS) showed the efficacy of blood pressure reduction in secondary stroke prevention." | 3.74 | Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy. ( Bugnicourt, JM; Canaple, S; Chillon, JM; Godefroy, O; Lamy, C, 2008) |
| " All patients were randomized to three groups based on the dosing schedule of chronopharmacotherapy: group 1 (n=59), patients receiving indapamide retard 1." | 3.01 | Cardioprotective potential of chronopharmacotherapy in patients with arterial hypertension who had a transient ischemic attack. ( Fendrikova, AV; Opolskaya, SV; Skibitsky, AV; Skibitsky, VV; Zabolotskich, TB, 2021) |
| "Stroke is a major cause of morbidity and mortality." | 2.42 | Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice. ( Jackson, G, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Opolskaya, SV | 1 |
| Skibitsky, VV | 1 |
| Fendrikova, AV | 1 |
| Zabolotskich, TB | 1 |
| Skibitsky, AV | 1 |
| Dézsi, CA | 1 |
| Farsang, C | 1 |
| Keenan, K | 1 |
| Hayen, A | 1 |
| Neal, BC | 2 |
| Irwig, L | 1 |
| Bath, P | 1 |
| Jackson, G | 1 |
| Fransen, M | 1 |
| Anderson, C | 2 |
| Chalmers, J | 2 |
| Chapman, N | 1 |
| Davis, S | 1 |
| MacMahon, S | 2 |
| Neal, B | 2 |
| Sega, R | 1 |
| Terent, A | 2 |
| Tzourio, C | 1 |
| Woodward, M | 3 |
| Muir, KW | 1 |
| Berthet, K | 1 |
| Chalmers, JP | 1 |
| MacMahon, SW | 1 |
| Bousser, MG | 1 |
| Colman, SA | 1 |
| Arima, H | 1 |
| Hart, RG | 1 |
| Colman, S | 1 |
| Rodgers, A | 1 |
| Diener, HC | 1 |
| Bugnicourt, JM | 1 |
| Chillon, JM | 1 |
| Canaple, S | 1 |
| Lamy, C | 1 |
| Godefroy, O | 1 |
| Einecke, D | 1 |
2 reviews available for indapamide and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.
Topics: Aged; Antihypertensive Agents; Family Practice; Humans; Indapamide; Ischemic Attack, Transient; Midd | 2003 |
[What should be done after the first TIA?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Clopi | 2007 |
8 trials available for indapamide and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Cardioprotective potential of chronopharmacotherapy in patients with arterial hypertension who had a transient ischemic attack.
Topics: Diastole; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Ventricular Function, Left | 2021 |
Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Diastole; Female; Humans; Hyp | 2009 |
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood | 2003 |
Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Comorbidity; Diabetes Compl | 2004 |
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Fibr | 2005 |
Post-stroke antihypertensive treatment study. A preliminary result.
Topics: Aged; Antihypertensive Agents; Cerebrovascular Disorders; China; Double-Blind Method; Female; Humans | 1995 |
PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Diuretics | 1999 |
[PROGRESS--a trial on blood pressure lowering after stroke and TIA. ACE inhibitors and diuretics reduce the risk of new stroke].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Double | 2002 |
5 other studies available for indapamide and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinati | 2018 |
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bloo | 2003 |
Secondary prevention for stroke and transient ischaemic attacks.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypercholesterolemia; Hyp | 2004 |
Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Diureti | 2008 |
[PROGRESS Study examines transient cerebral ischemia and stroke patients. Future goal: attaining basic blood pressure control].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Meth | 2001 |